State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF (XPH) is an ETF managed by State Street (SPDR). Its largest position is STATE STREET GLOBAL ADVISORS (GVMXX), representing 7.93% of fund assets.
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- XPH
- Type:
- ETF
- Manager:
- State Street (SPDR)
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
STATE STREET GLOBAL ADVISORS
|
7.93% | $24,400,789.00 | 24,400,789 |
|
-
Enliven Therapeutics, Inc.
|
2.45% | $7,538,042.40 | 192,297 |
|
-
CORCEPT THERAPEUTICS INC
|
2.29% | $7,053,081.01 | 174,971 |
|
-
TERNS PHARMACEUTICALS INC
|
2.16% | $6,653,105.84 | 126,197 |
|
-
PERRIGO Co plc
|
2.10% | $6,463,170.90 | 601,785 |
|
-
Axsome Therapeutics, Inc.
|
2.03% | $6,255,937.26 | 37,013 |
|
-
Innoviva, Inc.
|
1.99% | $6,135,216.20 | 263,314 |
|
-
Merck & Co., Inc.
|
1.98% | $6,110,732.00 | 50,800 |
|
-
PFIZER INC
|
1.97% | $6,072,215.76 | 216,247 |
|
-
Royalty Pharma plc
|
1.97% | $6,065,374.77 | 126,441 |
|
-
Elanco Animal Health Inc
|
1.96% | $6,024,353.57 | 251,749 |
|
-
Jazz Pharmaceuticals plc
|
1.96% | $6,018,973.90 | 31,838 |
|
-
ESPERION THERAPEUTICS INC
|
1.95% | $6,013,752.00 | 2,194,800 |
|
-
Edgewise Therapeutics, Inc.
|
1.95% | $6,000,655.50 | 190,497 |
|
-
MBX Biosciences, Inc.
|
1.95% | $5,992,208.40 | 200,744 |
|
-
Definium Therapeutics, Inc.
|
1.95% | $5,989,069.80 | 316,882 |
|
-
BRISTOL MYERS SQUIBB CO
|
1.94% | $5,969,476.25 | 98,425 |
|
-
ANI PHARMACEUTICALS INC
|
1.93% | $5,950,675.80 | 77,382 |
|
-
JOHNSON & JOHNSON
|
1.93% | $5,938,669.80 | 24,295 |
|
-
Tarsus Pharmaceuticals, Inc.
|
1.92% | $5,926,342.15 | 84,481 |
|
-
Trevi Therapeutics, Inc.
|
1.92% | $5,898,573.76 | 494,432 |
|
-
Pacira BioSciences, Inc.
|
1.90% | $5,844,043.60 | 258,586 |
|
-
Zoetis Inc.
|
1.89% | $5,825,625.22 | 49,282 |
|
-
CRINETICS PHARMACEUTICALS INC
|
1.88% | $5,798,197.44 | 159,642 |
|
-
NEKTAR THERAPEUTICS
|
1.88% | $5,792,406.70 | 80,506 |
|
-
Liquidia Corp
|
1.88% | $5,777,956.26 | 153,099 |
|
-
Amneal Pharmaceuticals, Inc.
|
1.88% | $5,773,449.11 | 464,477 |
|
-
Harmony Biosciences Holdings, Inc.
|
1.87% | $5,743,562.54 | 205,054 |
|
-
SUPERNUS PHARMACEUTICALS, INC.
|
1.86% | $5,733,764.94 | 110,926 |
|
-
Viatris Inc
|
1.85% | $5,709,123.35 | 422,585 |
|
-
Xeris Biopharma Holdings, Inc.
|
1.84% | $5,658,764.20 | 975,649 |
|
-
HARROW, INC.
|
1.83% | $5,635,006.38 | 159,813 |
|
-
Organon & Co.
|
1.79% | $5,525,313.77 | 922,423 |
|
-
Nuvation Bio Inc.
|
1.79% | $5,517,660.72 | 1,286,168 |
|
-
PHIBRO ANIMAL HEALTH CORP
|
1.79% | $5,510,258.75 | 99,625 |
|
-
Amylyx Pharmaceuticals, Inc.
|
1.79% | $5,496,240.70 | 395,413 |
|
-
Indivior Pharmaceuticals, Inc.
|
1.78% | $5,480,944.08 | 179,821 |
|
-
COLLEGIUM PHARMACEUTICAL, INC
|
1.78% | $5,480,889.52 | 165,736 |
|
-
ELI LILLY & Co
|
1.76% | $5,430,322.08 | 5,904 |
|
-
Prestige Consumer Healthcare Inc.
|
1.75% | $5,398,845.03 | 91,089 |
|
-
LIGAND PHARMACEUTICALS INC
|
1.73% | $5,327,460.60 | 26,684 |
|
-
OCULAR THERAPEUTIX, INC
|
1.71% | $5,263,452.81 | 621,423 |
|
-
OMEROS CORP
|
1.70% | $5,225,573.76 | 494,846 |
|
-
EyePoint, Inc.
|
1.66% | $5,100,276.53 | 395,677 |
|
-
ALUMIS INC.
|
1.60% | $4,937,517.81 | 224,127 |
|
-
Amphastar Pharmaceuticals, Inc.
|
1.45% | $4,460,270.79 | 227,681 |
|
-
Phathom Pharmaceuticals, Inc.
|
1.44% | $4,431,790.11 | 398,901 |
|
-
Theravance Biopharma, Inc.
|
1.42% | $4,362,867.45 | 268,815 |
|
-
Rapport Therapeutics, Inc.
|
1.37% | $4,208,630.16 | 134,504 |
|
-
ARVINAS, INC.
|
1.25% | $3,837,973.80 | 362,073 |
Advertisement (320x50)